Cadila Pharmaceuticals Ltd

About Cadila Pharmaceuticals Ltd

Cadila Pharmaceuticals Ltd. has been developing and manufacturing affordable medicines for patients around the world for last 7 decades. We are one of the few pharmaceutical companies that is vertically-integrated with a very strong presence in both API and Finished Formulations. Our extensive basket of formulations contains more than 850 products in several forms belonging to 45 therapeutic segments and 12 specialties including CVS, Gastro, analgesics, haematinics, Anti-infectives, respiratory agents, antidiabetics, immunologicals and oncology.

Certifications
  • IN
  • 2015
    On CPHI since
  • 4
    Certificates
  • 5000+
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Pharmaceutical Company (generic finished products)
Contact info
  • Cadila Corporate Campus, Sarkhej-Dholka Road, Bhat, 382210, Ahmedabad, Gujarat, India
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Cadila Pharmaceuticals Ltd (5)

  • Azivista 250 tab

    Product Azivista 250 tab

    Cadila pharmaceuticals ltd provides wide range of formulations which includes azivista 250 tab. Contact us for more information.
  • Azivista 500 tab

    Product Azivista 500 tab

    Cadila pharmaceuticals ltd provides wide range of formulations which includes azivista 500 tab. Contact us for more information.
  • Azivista cf tab

    Product Azivista cf tab

    Cadila pharmaceuticals ltd provides wide range of formulations which includes azivista cf tab. Contact us for more information.
  • Balocad tab

    Product Balocad tab

    Cadila pharmaceuticals ltd provides wide range of formulations which includes balocad tab. Contact us for more information.
  • Bectozid 1gm inj

    Product Bectozid 1gm inj

    Cadila pharmaceuticals ltd provides wide range of formulations which includes bectozid 1gm inj. Contact us for more information.